PER 1.35% 7.5¢ percheron therapeutics limited

Ann: Long COVID-19 strategic collaboration with US Experts, page-8

  1. 4,683 Posts.
    lightbulb Created with Sketch. 1086
    Actually, the FDA tox study feedback is due any week now...so don't have to wait months for news.

    I think this Long COVID study is for the IP - additional proteomics data to support the DMD and MS patents.

    Might grab more PR for the company than the DMD program

    .
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
7.5¢
Change
0.001(1.35%)
Mkt cap ! $67.61M
Open High Low Value Volume
7.7¢ 7.8¢ 7.4¢ $24.63K 325.4K

Buyers (Bids)

No. Vol. Price($)
2 142779 7.3¢
 

Sellers (Offers)

Price($) Vol. No.
7.5¢ 8181 1
View Market Depth
Last trade - 16.10pm 26/07/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.